[go: up one dir, main page]

HK1198010A - 治療腎小球硬化的二苯基磺酰胺內皮素和血管緊張素 ii 受體激動劑 - Google Patents

治療腎小球硬化的二苯基磺酰胺內皮素和血管緊張素 ii 受體激動劑 Download PDF

Info

Publication number
HK1198010A
HK1198010A HK14111720.8A HK14111720A HK1198010A HK 1198010 A HK1198010 A HK 1198010A HK 14111720 A HK14111720 A HK 14111720A HK 1198010 A HK1198010 A HK 1198010A
Authority
HK
Hong Kong
Prior art keywords
compound
formula
formulation
composition
tablets
Prior art date
Application number
HK14111720.8A
Other languages
English (en)
Other versions
HK1198010B (zh
Inventor
Zhang Jinkun
E Dziewanowska Zofia
Belder Rene
Henderson Ian
B Bogardus Joseph
Zhang Zhaoying
Original Assignee
Ligand Pharmaceuticals Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ligand Pharmaceuticals Inc. filed Critical Ligand Pharmaceuticals Inc.
Publication of HK1198010A publication Critical patent/HK1198010A/zh
Publication of HK1198010B publication Critical patent/HK1198010B/zh

Links

HK14111720.8A 2009-03-31 2014-11-20 治療腎小球硬化的二苯基磺酰胺內皮素和血管緊張素 ii 受體激動劑 HK1198010B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US165419P 2009-03-31
US165447P 2009-03-31

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
HK18104154.4A Division HK1244687B (zh) 2009-03-31 2014-11-20 治疗肾小球硬化症和iga引起的肾病的二苯基磺酰胺内皮素和血管紧张素ii受体拮抗剂

Related Child Applications (1)

Application Number Title Priority Date Filing Date
HK18104154.4A Addition HK1244687B (zh) 2009-03-31 2014-11-20 治疗肾小球硬化症和iga引起的肾病的二苯基磺酰胺内皮素和血管紧张素ii受体拮抗剂

Publications (2)

Publication Number Publication Date
HK1198010A true HK1198010A (zh) 2015-03-06
HK1198010B HK1198010B (zh) 2018-04-20

Family

ID=

Similar Documents

Publication Publication Date Title
US9993461B2 (en) Method for treating disorders associated with glomerular function
EP3525784B1 (en) Sparsentan for use in the treatment of alport syndrome
CN118791463A (zh) 取代的吡唑并哌啶羧酸
WO2015022547A1 (en) Bicyclic inhibitors
TW202139996A (zh) 治療ａｐｏｌ－１依賴性局灶性節段性腎小球硬化之方法
CN111225917A (zh) 取代咪唑并吡啶酰胺及其用途
CA3124127A1 (en) Amorphous sparsentan compositions
WO2007106468A2 (en) Formulations of sitaxsentan sodium
HK1198010A (zh) 治療腎小球硬化的二苯基磺酰胺內皮素和血管緊張素 ii 受體激動劑
HK1198010B (zh) 治療腎小球硬化的二苯基磺酰胺內皮素和血管緊張素 ii 受體激動劑
HK1244687B (zh) 治疗肾小球硬化症和iga引起的肾病的二苯基磺酰胺内皮素和血管紧张素ii受体拮抗剂
HK40118187A (zh) 取代的吡唑并哌啶羧酸
HK40118186A (zh) 取代的吡唑并哌啶羧酸
HK40091213A (zh) 取代的吡唑并哌啶羧酸
HK40073287B (zh) 取代的吡唑并哌啶羧酸
US8476307B2 (en) Pharmaceutical composition based on idazoxan, salts, hydrates or polymorphs thereof
EA049460B1 (ru) Замещенные пиразолопиперидинкарбоновые кислоты
HK40021283A (zh) 取代咪唑并吡啶酰胺及其用途
US20050176798A1 (en) Pharmaceutical composition based on idazoxan, salts, hydrates or polymorphs thereof